A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling - ScienceDirect
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
New insights into acquired endocrine resistance of breast cancer
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism: Trends in Endocrinology & Metabolism
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Estrogen signaling and regulation of Notch. The ERα ligand... | Download Scientific Diagram
Frontiers | G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Cells | Free Full-Text | Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Frontiers | Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
